Stocktoria
Chemours Co CC
NYSE · stock · Chemicals & Allied Products · website · IPO 2015-06-19
Chemours Co financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $5.8B | $6.1B | $6.8B | $6.3B | $5.0B | $5.5B | $6.6B | $6.2B | $5.4B |
| Gross profit | $902.0M | $1.1B | $1.3B | $1.6B | $1.4B | $1.1B | $1.1B | $2.0B | $1.7B | $1.1B |
| R&D expense | $108.0M | $109.0M | $108.0M | $118.0M | $107.0M | $93.0M | $80.0M | $82.0M | $81.0M | $81.0M |
| SG&A expense | $799.0M | $598.0M | $1.3B | $710.0M | $592.0M | $527.0M | $548.0M | $657.0M | $626.0M | $946.0M |
| Interest expense | $269.0M | $263.0M | $208.0M | $163.0M | $185.0M | $210.0M | $208.0M | $195.0M | $214.0M | $219.0M |
| Income tax | $109.0M | $37.0M | -$66.0M | $163.0M | $68.0M | -$40.0M | -$72.0M | $159.0M | $165.0M | -$18.0M |
| Net income | -$386.0M | $69.0M | -$253.0M | $578.0M | $608.0M | $219.0M | -$52.0M | $995.0M | $746.0M | $7.0M |
| EPS (diluted) | $-2.57 | $0.46 | $-1.70 | $3.65 | $3.60 | $1.32 | $-0.32 | $5.45 | $3.91 | $0.04 |
| Operating cash flow | $264.0M | -$633.0M | $556.0M | $755.0M | $814.0M | $807.0M | $650.0M | $1.1B | $640.0M | $594.0M |
| Free cash flow | $51.0M | -$993.0M | $186.0M | $448.0M | $537.0M | $540.0M | $169.0M | $642.0M | $229.0M | $256.0M |
| Cash & equivalents | $670.0M | $713.0M | $1.2B | $1.1B | $1.5B | $1.1B | $943.0M | $1.2B | $1.6B | $902.0M |
| Inventory | $1.6B | $1.5B | $1.3B | $1.4B | $1.1B | $939.0M | $1.1B | $1.1B | $935.0M | $767.0M |
| Total assets | $7.4B | $7.5B | $8.2B | $7.6B | $7.5B | $7.1B | $7.3B | $7.4B | $7.3B | $6.1B |
| Total liabilities | $7.1B | $6.9B | $7.5B | $6.5B | $6.5B | $6.3B | $6.6B | $6.3B | $6.4B | $6.0B |
| Shareholders' equity | $251.0M | $572.0M | $723.0M | $1.1B | $1.1B | $815.0M | $695.0M | $1.0B | $865.0M | $104.0M |
Growth · year-over-year · Revenue CAGR 0.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +0.4% | -4.9% | -11.0% | +7.7% | +27.7% | -10.1% | -16.8% | +7.4% | +14.5% | -5.5% |
| Net income growth | -659.4% | — | -143.8% | -4.9% | +177.6% | — | -105.2% | +33.4% | +10557.1% | — |
| EPS growth | -658.7% | — | -146.6% | +1.4% | +172.7% | — | -105.9% | +39.4% | +9675.0% | — |
| Free cash flow growth | — | -633.9% | -58.5% | -16.6% | -0.6% | +219.5% | -73.7% | +180.3% | -10.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.